AquigenBio

Catalyzing Innovation with
Aquigen’s Impurity Standards

Categories

Sort Product

'Lenacapavir' related Reference Standards & Products

Showing 55–63 of 63 results

 

As a supplier of high-purity analytical standards, we offer a comprehensive portfolio of Lenacapavir impurities designed for pharmaceutical retailers, API manufacturers, and regulatory bodies. Our products support every stage of drug development and quality assurance—from forced-degradation profiling to method validation and stability studies.

🧪 Our Popular Product Range
Lenacapavir Impurity 1 (CAS 2189680‑65‑5):
Low-molecular-weight degradation fragment (~282 g/mol; molecular formula C₁₀H₇F₅N₂O₂), ideal for calibration of early degradation peaks in HPLC/LC‑MS assays

Lenacapavir Impurity 7:
(R)-1 (3‑bromo‑6‑(3‑methyl‑3‑(methylsulfonyl)but‑1‑yn‑1‑yl)pyridin‑2‑yl)-2‑(3,5‑difluorophenyl)ethan-1‑amine, MW ~457.3 g/mol—commonly used to monitor forced‑degradation products and validate stability testing

Lenacapavir Impurity 9:
High‑molecular-weight impurity (~721.5 g/mol; molecular formula C₂₉H₂₄BrF₇N₄O₃S), often encountered as a late-stage synthetic impurity or degradation marker

Other Available Standards:
Including Impurities 4, 5, and 60—representing bromopyridine intermediates, process markers, and custom impurities with detailed char-acterization data

✅ Why Our Standards Are Trusted
Regulatory-Grade Quality:
Each impurity standard is supplied with a Certificate of Analysis (CoA), stability data, and traceability to pharmacopeial reference or internal benchmarks to support DMF, ANDA, NDA approvals or stability submissions

Full Characterization:
Provided technical documentation includes purity analysis, structural confirmation (NMR, MS), and retention behavior—crucial for reliable method development and validation

Analytical & Method Validation Utility:
Ideal for forced-degradation studies, impurity profiling, and QC testing of Lenacapavir API or formulated dosage forms

Custom & Isotopically Labeled Compounds:
Capabilities include traceable isotopes (e.g., ^13C/^2H₃‑Lenacapavir), metabolites, and nitrosamine impurity analogs, based on customer specifications

Compliance with ICH Q3A/Q3B Guidelines:
Supports global regulatory alignment by providing reference standards for specified and unspecified impurities, aiding impurity limits documentation and validation.

Shopping Cart

No products in the cart.

No products in the cart.